{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T13:36:50Z","timestamp":1778333810101,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"am","delay-in-days":361,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinical-colorectal-cancer.com","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Colorectal Cancer"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.clcc.2024.05.005","type":"journal-article","created":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T23:32:01Z","timestamp":1716593521000},"page":"346-353.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Survival Outcomes in Patients with Monobloc-Resected Stage IIC (pT4bN0) Colon Cancer: A Retrospective Observational Cohort Study"],"prefix":"10.1016","volume":"23","author":[{"given":"Juliette","family":"Logeart","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Samaille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Falcoz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magali","family":"Svrcek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Dubreuil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dewi","family":"Vernerey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romain","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascale","family":"Cervera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Valverde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yann","family":"Parc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5103-7095","authenticated-orcid":false,"given":"Thierry","family":"Andr\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clcc.2024.05.005_bib0001","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1158\/1055-9965.EPI-15-0578","article-title":"Global cancer incidence and mortality rates and trends\u2014an update","volume":"25","author":"Torre","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"10.1016\/j.clcc.2024.05.005_bib0002","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3322\/caac.21388","article-title":"The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.clcc.2024.05.005_bib0003","first-page":"3","article-title":"Clinical practice guidelines for the surgical management of colon cancer: a consensus statement of the Hellenic And Cypriot Colorectal Cancer Study Group by the HeSMO","volume":"29","author":"Xynos","year":"2016","journal-title":"Ann Gastroenterol"},{"issue":"9604","key":"10.1016\/j.clcc.2024.05.005_bib0004","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1016\/S0140-6736(07)61866-2","article-title":"Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study","volume":"370","author":"Group","year":"2007","journal-title":"Lancet Lond Engl"},{"issue":"10","key":"10.1016\/j.clcc.2024.05.005_bib0005","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.annonc.2020.06.022","article-title":"ESMO guidelines committee","volume":"31","author":"Argil\u00e9s","year":"2020","journal-title":"Ann Oncol"},{"issue":"35","key":"10.1016\/j.clcc.2024.05.005_bib0006","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.1200\/JCO.2015.63.4238","article-title":"Adjuvant fluorouracil, leucovorin, and oxaliplatin in stage II to III colon cancer: updated 10-year survival and outcomes according to BRAF mutation and mismatch repair status of the MOSAIC study","volume":"33","author":"Andr\u00e9","year":"2015","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.clcc.2024.05.005_bib0007","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1200\/JCO.21.02538","article-title":"Adjuvant therapy for stage II colon cancer: ASCO guideline update","volume":"40","author":"Baxter","year":"2022","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"1","key":"10.1016\/j.clcc.2024.05.005_bib0008","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/0284186X.2014.975839","article-title":"Risk of recurrence in patients with colon cancer stage II and III: a systematic review and meta-analysis of recent literature","volume":"54","author":"B\u00f6ckelman","year":"2015","journal-title":"Acta Oncol"},{"issue":"6","key":"10.1016\/j.clcc.2024.05.005_bib0009","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1200\/JCO.2008.19.5362","article-title":"Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials","volume":"20;27","author":"Sargent","year":"2009","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.clcc.2024.05.005_bib0010","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1200\/JCO.2009.24.0952","article-title":"Revised TN categorization for colon cancer based on national survival outcomes data","volume":"28","author":"Gunderson","year":"2010","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.clcc.2024.05.005_bib0011","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/his.13820","article-title":"Detailed pathological analysis of the advancing edge of the tumour can effectively stratify clinical T4b colorectal cancer patients","volume":"74","author":"Kim","year":"2019","journal-title":"Histopathology"},{"key":"10.1016\/j.clcc.2024.05.005_bib0012","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1186\/s12885-016-2446-3","article-title":"Poor survival in stage IIB\/C (T4N0) compared to stage IIIA (T1-2 N1, T1N2a) colon cancer persists even after adjusting for adequate lymph nodes retrieved and receipt of adjuvant chemotherapy","volume":"16","author":"Chu","year":"2016","journal-title":"BMC Cancer"},{"issue":"10","key":"10.1016\/j.clcc.2024.05.005_bib0013","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1200\/JCO.2004.09.059","article-title":"Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?","volume":"22","author":"Gill","year":"2004","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"4","key":"10.1016\/j.clcc.2024.05.005_bib0014","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/SLA.0000000000003454","article-title":"Perioperative FOLFOX 4 versus FOLFOX 4 plus cetuximab versus immediate surgery for high-risk stage II and III colon cancers: a phase II multicenter randomized controlled trial (PRODIGE 22)","volume":"271","author":"Karoui","year":"2020","journal-title":"Ann Surg"},{"issue":"8","key":"10.1016\/j.clcc.2024.05.005_bib0015","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1200\/JCO.22.00046","article-title":"Preoperative chemotherapy for operable colon cancer: mature results of an international randomized controlled trial","volume":"41","author":"Morton","year":"2023","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.clcc.2024.05.005_bib0016","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1053\/j.gastro.2009.12.064","article-title":"Microsatellite instability in colorectal cancer","volume":"138","author":"Boland","year":"2010","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.clcc.2024.05.005_bib0017","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/DCR.0000000000001914","article-title":"Is microsatellite status associated with prognosis in stage II colon cancer with high-risk features?","volume":"64","author":"Cavallaro","year":"2021","journal-title":"Dis Colon Rectum"},{"issue":"20","key":"10.1016\/j.clcc.2024.05.005_bib0018","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1200\/JCO.2009.27.1825","article-title":"Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer","volume":"28","author":"Sargent","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clcc.2024.05.005_bib0019","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejca.2020.02.009","article-title":"Guidelines for time-to-event end-point definitions in adjuvant randomised trials for patients with localised colon cancer: results of the DATECAN initiative","volume":"130","author":"Cohen","year":"2020","journal-title":"Eur J Cancer Oxf Engl"},{"issue":"20","key":"10.1016\/j.clcc.2024.05.005_bib0020","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1093\/jnci\/djj396","article-title":"Population-based assessment of the surgical management of locally advanced colorectal cancer","volume":"98","author":"Govindarajan","year":"2006","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.clcc.2024.05.005_bib0021","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s11605-018-3962-z","article-title":"The impact of a multivisceral resection and adjuvant therapy in locally advanced colon cancer","volume":"23","author":"Leijssen","year":"2019","journal-title":"J Gastrointest Surg"},{"issue":"6","key":"10.1016\/j.clcc.2024.05.005_bib0022","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1200\/JCO.20.01330","article-title":"Duration of adjuvant doublet chemotherapy (3 or 6 months) in patients with high-risk stage II colorectal cancer","volume":"39","author":"Iveson","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clcc.2024.05.005_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejca.2021.07.027","article-title":"Colon cancer patients with mismatch repair deficiency are more likely to present as acute surgical cases","volume":"157","author":"Gkekas","year":"2021","journal-title":"Eur J Cancer"},{"issue":"10","key":"10.1016\/j.clcc.2024.05.005_bib0024","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1200\/JCO.2010.30.1366","article-title":"Value of mismatch repair, KRAS, and BRAF mutations in predicting recurrence and benefits from chemotherapy in colorectal cancer","volume":"29","author":"Hutchins","year":"2011","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.clcc.2024.05.005_bib0025","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41591-020-0805-8","article-title":"Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers","volume":"26","author":"Chalabi","year":"2020","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.clcc.2024.05.005_bib0026","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S2468-1253(21)00348-4","article-title":"Neoadjuvant PD-1 blockade with toripalimab, with or without celecoxib, in mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): a single-centre, parallel-group, non-comparative, randomised, phase 2 trial","volume":"7","author":"Hu","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.clcc.2024.05.005_bib0027","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1200\/JCO.22.01351","article-title":"Neoadjuvant pembrolizumab in localized microsatellite instability high\/deficient mismatch repair solid tumors","volume":"41","author":"Ludford","year":"2023","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"}],"container-title":["Clinical Colorectal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002824000367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002824000367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T16:08:08Z","timestamp":1732723688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1533002824000367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1533002824000367"],"URL":"https:\/\/doi.org\/10.1016\/j.clcc.2024.05.005","relation":{},"ISSN":["1533-0028"],"issn-type":[{"value":"1533-0028","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survival Outcomes in Patients with Monobloc-Resected Stage IIC (pT4bN0) Colon Cancer: A Retrospective Observational Cohort Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Colorectal Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clcc.2024.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}